Table 3 Completeness of Databases
From: Clinical decision support tools: analysis of online drug information databases
Completeness Score | CP | EP | FC | LC | MM | EF | RL |
|---|---|---|---|---|---|---|---|
Dosage/Schedule | 2.88 | 2.92 | 2.93 | 2.92 | 3.00 | 2.92 | 3.00 |
Drug Interactions | 2.93 | 2.69 | 2.79 | 2.77 | 3.00 | 2.67 | 2.42 |
Methods of Administration | 2.92 | 2.67 | 2.92 | 3.00 | 2.92 | 2.60 | 2.58 |
Adverse Drug Reactions | 2.69 | 2.89 | 2.92 | 2.92 | 3.00 | 2.89 | 2.40 |
Over-the-Counter | 2.73 | 2.75 | 2.64 | 2.89 | 2.17 | 2.75 | 2.33 |
Indications/Unlabeled Uses | 3.00 | 2.67 | 3.00 | 3.00 | 3.00 | 2.67 | 3.00 |
Identification/Content | 2.90 | 2.86 | 2.88 | 2.89 | 2.88 | 2.80 | 2.88 |
Pharmacokinetics | 2.88 | 2.60 | 2.89 | 2.63 | 2.67 | 3.00 | 2.50 |
Compatibility/Stability | 2.88 | 2.75 | 2.83 | 2.89 | 3.00 | 3.00 | 2.67 |
Contraindications | 3.00 | 3.00 | 3.00 | 2.86 | 2.89 | 3.00 | 2.75 |
Dietary Supplements | 3.00 | 2.86 | 2.88 | 2.33 | 3.00 | NA | 2.80 |
Pharmacology/MOA | 2.88 | 2.71 | 3.00 | 2.63 | 3.00 | 2.71 | 3.00 |
Pregnancy and Lactation | 3.00 | 2.83 | 3.00 | 3.00 | 2.88 | 2.83 | 2.63 |
Foreign Drug Identification | 3.00 | NA | 1.00 | 3.00 | 3.00 | NA | NA |
Cost and Economics | 3.00 | 3.00 | 3.00 | 3.00 | NA | 3.00 | 3.00 |
(%) | 96.4 | 93.2 | 95.8 | 95.2 | 97.0 | 93.2 | 89.6 |